Panagora Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,977
| Closed | -$447K | – | 1524 |
|
|
2022
Q3 | $447K | Buy |
1,977
+16
| +0.8% | +$3.62K | ﹤0.01% | 1172 |
|
|
2022
Q2 | $371K | Sell |
1,961
-23
| -1% | -$4.35K | ﹤0.01% | 1254 |
|
|
2022
Q1 | $494K | Hold |
1,984
| – | – | ﹤0.01% | 1213 |
|
|
2021
Q4 | $309K | Buy |
1,984
+1,229
| +163% | +$191K | ﹤0.01% | 1366 |
|
|
2021
Q3 | $151K | Buy |
755
+732
| +3,183% | +$146K | ﹤0.01% | 1669 |
|
|
2021
Q2 | $6K | Buy |
+23
| New | +$6K | ﹤0.01% | 2455 |
|
|
2015
Q4 | – | Sell |
-544
| Closed | -$257K | – | 2380 |
|
|
2015
Q3 | $257K | Buy |
544
+169
| +45% | +$79.8K | ﹤0.01% | 1533 |
|
|
2015
Q2 | $213K | Buy |
375
+303
| +421% | +$172K | ﹤0.01% | 1643 |
|
|
2015
Q1 | $618K | Buy |
+72
| New | +$618K | ﹤0.01% | 1236 |
|